Summary
Human glioma-derived cell cultures and lines have proven to be of significant value in the study of the basic properties that contribute to the highly malignant, invasive and angiogenic phenotype of glioblastoma multiforme tumors. It is frequently difficult to establish lines that retain glial tumor properties in long term culture. The SNB-19 cell line has maintained and exhibited properties of transformation, differentiation, autocrine growth response, and tumorigenesis while remaining in culture for over 13 yr and undergoing over 200 passages. This human line has been utilized in a wide range of studies related to the basic properties of human glioblastoma multiforme. In this report, we summarize the immunologic, biochemical, and cytogenetic properties of this versatile cell line and its utility for additional mechanistic investigation into the pathophysiology of the progression of human malignant gliomas.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Allen, R. D.; Travis, J. L.; Allen, N. S., et al. Video-enhanced contrast polarization (AVEC-POL) microscopy: a new method applied to the detection of birefringence in the motile reticulopodial network ofAllogromia laticollaris. Cell Motil. Cytoskel. 1:275–289; 1981.
Arai, K.; Horie, Y.; Kurimoto, M., et al. A cell line of human malignant astrocytoma producing autocrine growth factor. In Vitro Cell. Dev. Biol. 27A:606–614; 1991.
Bigner, S. H.; Mark, J.; Burger, P. C., et al. Specific chromosomal abnormalities in malignant human gliomas. Cancer Res. 88:405–411; 1988.
Bilzer, T.; Stavrou, D.; Dahme, E., et al. Morphological, immunocytochemical and growth characteristics of three human glioblastomas established in vitro. Virchows Arch. A Pathol. Anat. 418:281–293; 1991.
Black, P. McL.; Kornblith, P. L.; Davison, P. F., et al. Immunological, biochemical, ultrastructural, and electrophysiological characteristics of a human glioblastoma-derived cell culture line. J. Neurosurg. 56:62–72; 1982.
Bocchini, V.; Casalone, R.; Collini, P., et al. Changes in glial fibrillary acidic protein and karyotype during culturing of two cell lines established from human glioblastoma multiforme. Cell Tissue Res. 265:73–81; 1991.
Bullard, D. E.; Bigner, S. H.; Bigner, D. D. The morphologic response of cell lines derived from human gliomas to dibutyryl adenosine 3′:5′-cyclic monophosphate. J. Neuropathol. Exp. Neurol. 40:230–246; 1981.
Dexter, D. L.; Spremulli, E. N.; Fligiel, Z., et al. Heterogeneity of cancer cells from a single human colon carcinoma. Am. J. Med. 71:949–956; 1981.
Eng, L. F.; Vanderhaeghen, J. J.; Bignami, A., et al. An acidic protein isolated from fibrous astrocytes. Brain Res. 28:351–354; 1971.
Gillaspy, G. E.; Miller, R. H.; Samols, D., et al. Antigenic and differentiative heterogeneity among human glioblastomas. Cancer Lett. 68:215–224; 1993.
Goldfarb, R. H.; Wasserman, R. B.; Herberman, R. B., et al. Non-granular proteolytic enzymes of rat interleukin-2 activated natural killer cells. I. Subcellular localization and functional roles. J. Immunol. 149:2061–2066; 1992.
Gross, J. L.; Behrens, D. L.; Mullins, D. E., et al. Plasminogen activator and inhibitor activity in human glioma cells and modulation by sodium butyrate. Cancer Res. 48:291–296; 1988.
Gross, J. L.; Morrison, R. S.; Eidsvoog, K., et al. Basic fibroblast growth factor: a potential autocrine regulator of human glioma cell growth. J. Neurosci. Res. 27:689–696; 1990.
Hibbs, M. S.; Hasty, K. A.; Seyer, J. M., et al. Biochemical and immunological characterization of the secreted forms of human neutrophil gelatinase. J. Biol. Chem. 260:2493–2500; 1985.
International system for cytogenic nomenclature. Guidelines for cancer cytogenetics. In: Mitelman, F., ed. Supplement to an international system for human cytogenetic nomenclature. Basel: S. Karger; 1991.
Jenkins, R. B.; Kimmel, D. W.; Moertel, C. A., et al. A cytogenetic study of 53 human gliomas. Cancer Genet. Cytogenet. 39:253–279; 1989.
Klein, U.; Gernold, M.; Kloetzel, P. M. Cell specific accumulation ofDrosophila proteasomes (MCP) during early development. J. Cell. Biol. 111:2275–2282; 1990.
Klinger, H. P. Rapid processing of primary embryonic tissues for chromosome banding pattern analysis. Cytogenetics 11:424–455; 1972.
Lowry, O. H.; Rosebrough, N. J.; Farr, A. L., et al. Protein measurement with the Folin reagent. J. Biol. Chem. 193:265–275; 1951.
Morrison, R. S. Suppression of basic fibroblast growth factor expression by antisense oligodeoxynucleotides inhibits the growth of transformed human astrocytes. J. Biol. Chem. 266:728–234; 1991.
Morrison, R. S.; Gross, J. L.; Herblin, W. F., et al. Basic fibroblast growth factor-like activity and receptors are expressed in a human glioma cell line. Cancer Res. 50:2524–2529; 1990.
Morrison, R. S.; Sharma, A.; De Vellis, J., et al. Basic fibroblast growth factor supports the survival of cerebral cortical neurons in primary culture. Proc. Natl. Acad. Sci. USA 83:7537–7541; 1986.
Moscatelli, D.; Presta, M.; Joseph-Silverstein, J., et al. Both normal and tumor cells produce basic fibroblast growth factor. J. Cell. Physiol. 129:273–276; 1986.
Paetau, A. Glial fibrillary acidic protein, vimentin and fibronectin in primary cultures of human glioma and fetal brain. Acta. Neuropathol. (Berl.) 75:448–455; 1988.
Sawaya, R.; Highsmith, R. Brain tumors and the fibrinolytic system. In: Kornblith, P. L.; Walker, M. D., eds. Advances in neurooncology. Mount Kisco, NY: Futura; 1988:347–386.
Schagger, H.; von Jagow, G. Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal. Biochem. 166:368–379; 1987.
Shimbara, N.; Orino, E.; Sone, S., et al. Regulation of gene expression of proteasomes (multi-protease complexes) during growth and differentiation of human hematopoietic cells. J. Biol. Chem. 267:18100–18109; 1992.
Smith, P. K.; Krohn, R. I.; Hermanson, G. T., et al. Measurement of protein using bicinchoninic acid. Anal. Biochem. 150:76–85; 1985.
Sporn, M. B.; Roberts, A. B. Autocrine growth factors and cancer. Nature 313:745–747; 1985.
Thorgeirsson, U. P.; Lindsay, C. K.; Cottam, D. W., et al. Tumor invasion, proteolysis, and angiogenesis. J. Neuro-Oncol. 1994; 18(2):89–103.
Vassalli, J. D.; Sappino, A. P.; Belin, D. The plasminogen activator/plasmin system. J. Clin. Invest. 88:1067–1072; 1991.
Wasserman, K.; Kitson, R. P.; Rivett, A. J. Nongranular proteolytic enzymes of rat IL-2-activated natural killer cells. II. Purification and identification of rat A-NKP 1 and A-NKP 2 as constituents of the multicatalytic proteinase (proteasome) complex. J. Cell. Biochem. 55:1–13; 1994.
Welch, W. C.; Kornblith P. L.; Bradley, M. K. Characterization of human gliomas using chemiluminescent identification and quantitation of intracellular proteins. Surg. Forum 43:532–535; 1992.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Welch, W.C., Morrison, R.S., Gross, J.L. et al. Morphologic, immunologic, biochemical, and cytogenetic characteristics of the human glioblastoma-derived cell line, SNB-19. In Vitro Cell Dev Biol - Animal 31, 610–616 (1995). https://doi.org/10.1007/BF02634314
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02634314